To address potential mechanisms for oxida- 
(LDL) with glucose produced AGE moieties that were attached to both the lipid and the apoprotein components. Oxidized LDL formed concomitantly with AGE-modified LDL. Of signiflicance, AGE ELISA analysis of LDL specimens isolated from diabetic individuals revealed increased levels of both apoprotein-and. lipid-linked AGEs when compared to specimens obtained from normal, nondiabetic controls. Circulating levels of oxidized LDL were elevated in diabetic patients and correlated significantly with lipid AGE levels. These data support the concept that AGE oxidation plays an important and perhaps primary role in initiating lipid oxidation in vivo.
The oxidative modification of lipids in vivo has been proposed to play a central role in atherogenesis and to contribute to the diverse vascular sequelae of diabetes and aging (1) . Oxidation of the lipid component of low density lipoprotein (LDL) , for example, leads to the loss of LDL recognition by cellular LDL receptors and in the preferential uptake of oxidized LDL by macrophage scavenger receptors (2-4). The enhanced endocytosis of oxidized LDL by vascular wall macrophages transforms them into the lipid-laden foam cells that characterize early atherosclerotic lesions. This is followed progressively by the development of fatty streaks and the complex, proliferative lesions that ultimately cause arterial insufficiency and occlusion (1-5).
Despite increased investigation into the biological role of lipid oxidation, there has been little insight into the biochemical processes that initiate lipid oxidation in vivo. In vitro studies have demonstrated that metal-catalyzed peroxidation reactions occur readily at the unsaturated bonds within fatty acid residues. Polyunsaturated fatty acids are particularly sensitive to peroxidation because bisallylic hydrogens are more easily abstracted by free radical processes. Diene conjugation then occurs and hydroperoxides form. Once lipid oxidation is initiated, fatty acids decompose readily to a variety ofreactive aldehydes that rapidly propagate oxidative reactions (6, 7) .
It is important to note that in the absence of transition metals or free radicals, oxygen itself is a poor oxidant. The electronic structure of triplet (ground state) oxygen has two
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. unpaired electrons at the ir antibonding level (31g). Thus, the reaction of oxygen with molecules of singlet multiplicity such as unsaturated fatty acids is spin forbidden. Singlet oxygen (1Ag and 1lg) may add directly to unsaturated bonds to produce allylic hydroperoxides; however, this reaction does not initiate the abstraction of allylic hydrogens (6, 7). Furthermore, there is insufficient singlet oxygen available under normal, physiological conditions to initiate lipid peroxidation. Significant amounts of the superoxide anion (O -) do form in vivo (0.1-1.0 AM), but superoxide also is incapable of abstracting bisallylic hydrogens from unsaturated bonds. Under acidic conditions, superoxide may initiate oxidative modification by forming perhydroxyl radicals (HOO ) or by reacting with transition metals to form reactive hydroxyl radicals (HO') (8, 9). Nevertheless, low trace metal concentrations, the high availability of ligands that form tight coordination complexes with metals, and the abundant antioxidant capacity of plasma suggest that metal-catalyzed autoxidation and reactive oxygen species play little, if any, role in mediating lipid oxidation in vivo (10) (11) (12) .
In the present study, we investigated the possibility that glucose-mediated advanced glycosylation reactions initiate oxidative modification in vivo. Advanced glycosylation is a major pathway for the posttranslational modification oftissue proteins and begins with the nonenzymatic addition of sugars such as glucose to the primary amino groups of proteins (13, 14) . These early glucose-denrved Schiff base and Amadori products then undergo a series of inter-and intramolecular rearrangement, dehydration, and oxidation-reduction reactions to produce the "late" products termed advanced glycosylation end products (AGEs). Excessive accumulation of AGEs on tissue proteins has been implicated in the pathogenesis of many of the sequelae of diabetes and normal aging (13) (14) (15) 
RESULTS
Two model phospholipids were incubated with glucose at physiological pH and temperature for increasing time intervals. PE contains a free amino group that can react with glucose-derived carbonyls to form Schiff base and Amadori products. PC was used as a control. In contrast to PE, PC contains a blocked, tertiary amine that cannot react with glucose to form the initial Schiff base. Anaerobic, buffered suspensions of PE or PC (14 mM) were prepared and incubated at 37°C with glucose (500 mM) and EDTA (1 mM). PE but not PC was observed to react with glucose to form products with the absorbance and the fluorescence properties of AGEs (Figs. 1 and 2) . The lipid-derived fluorophores showed an excitation maximum of 360 nm and an emission maximum of 440 nm. Progress curves for the development of lipid-derived AGEs are shown in Fig. 2 . The time-dependent formation of lipid-derived AGEs was confirmed by immunoassay with a specific anti-AGE antibody (Fig. 2C) (23) . Immunoreactive AGEs formed in incubation mixtures that contained PE and glucose, but not PE alone, PC and glucose, or PC alone.
To assess the contribution of advanced glycosylation reactions to lipid oxidation, the PE and PC used in these experiments contained esterified oleic acid, a monounsaturated fatty acid. Monounsaturated residues are 10-to 30-fold less susceptible to oxidation than polyunsaturated fatty acids (7) but, once oxidized, can undergo ,3scission to form reactive aldehydes that are representative of initiation reactions. Polyunsaturated fatty acids, although more susceptible to oxidation, readily undergo complex rearrangement and free radical propagation reactions (6, (27) (28) (29) . Diene conjugation is a frequently measured early parameter of polyunsaturated fatty acid oxidation (6, 7). However, this analysis cannot be performed in glucose-containing incubations because of ultraviolet absorbance changes that result from advanced glycosylation.
Buffered phospholipid incubation mixtures were extracted with chloroform/methanol to remove glucose and the lipidsoluble material was then assayed for the presence of reactive, fatty acid-derived aldehydes by reaction with TBA. Under defined experimental conditions, TBA condenses with a variety of reactive aldehydes to form addition products that can be quantitated by reference to a standard solution of MDA (24, 25). As shown in Fig. 2D , lipid oxidation products formed at a rate that was slightly delayed but parallel to the rate of AGE formation. Control incubation mixtures that contained either PE alone, PC and glucose, or PC alone did not produce significant lipid oxidation. Of note, the inclusion of lysine (50 mM) in aqueous suspensions of PC and glucose did not lead to the formation of lipid oxidation products, pointing to the necessity for proximity of AGEs to unsaturated residues (data not shown).
Aminoguanidine interferes with the formation of proteinbound AGEs and was found to also inhibit the formation of AGEs that result from the reaction of glucose with phospholipid. Aminoguanidine appeared to inhibit only partially the formation of AGE-associated chromophores ( Fig. 2A) . This may be explained by the formation of aminoguanidine AGE addition products, which themselves absorb in the near ultraviolet (30 prevent formation of AGEs, however, indicating that it prevents oxidative modification of lipid independent of any effect on advanced glycosylation. AGE formation generally follows complex, higher-order reaction kinetics that reflect in part the generation ofreactive intermediates, which produce AGEs at a faster rate than the starting reactant, glucose (13, 14) . Curvilinear, time-and concentration-dependent increases in advanced glycosylation occur when glucose reacts with protein or amino acids. Similar curvilinear increases in the formation of AGEs were observed by incubating glucose with PE (Fig. 2) . Logarithmic transformation of measurements that were obtained with PE and increasing glucose concentrations demonstrated that four measured reaction products: chromophores, fluoro- phores, AGE epitopes, and oxidized lipids appeared to follow similar, nonlinear reaction kinetics (Fig. 3) .
Aminoguanidine prevents AGE formation by reacting with glucose-derived products that form at intermediate stages of the advanced glycosylation pathway. Early Amadori products, for example, rearrange to dideoxyosones that react with aminoguanidine to form triazine or dihydrazone products (30). Thus, aminoguanidine also might react directly with the aldehydes that form during fatty acid oxidation. In agreement with recent reports (31, 32), the addition of aminoguanidine to MDA inhibited the formation of TBA-reactive substances in a concentration-dependent manner (data not shown). These data suggest that aminoguanidine inhibits AGEmediated fatty acid oxidation by two mechanisms: inhibition of lipid advanced glycosylation and by direct reaction with reactive aldehydes that form during fatty acid oxidation.
The contribution of advanced glycosylation to the oxidative modification of LDL first was assessed by incubating LDL with glucose in vitro in the presence of EDTA. LDL was removed at intervals and analyzed for advanced glycosylation and oxidative modification. Portions of LDL were fractionated into the lipid and apoprotein (ApoB) components, and the AGEs were measured by an AGE-specific ELISA. Incubation of LDL with 200 mM glucose for 3 days resulted in the formation ofreadily measurable levels ofAGEs on both lipid and apoprotein (Fig. 4) . These measurements indicate that lipid-linked AGEs are present at a specific activity that is 100-fold greater than apoprotein-linked AGEs. Because of possible differences in the immunoreactivity of anti-AGE antibody with lipid AGEs versus apoprotein AGEs, it may not be possible to compare quantitatively AGE modification on lipid versus protein. Nevertheless, it can be concluded that in vitro there is a markedly higher rate of formation of AGEs on lipid than on apoprotein. Measurements of oxidative modification revealed that LDL was oxidized during the formation of AGEs. Lipid oxidation products formed at a more rapid rate than was observed during the incubation of PE and glucose (Fig. 2D ) and this most likely is due to the presence in LDL of polyunsaturated fatty acids that rapidly propagate oxidative reactions. Aminoguanidine inhibited significantly both the advanced glycosylation and the oxidative modification of LDL.
To begin to define the relationship between advanced glycosylation and LDL oxidation in vivo, LDL was isolated from both nondiabetic and diabetic individuals and analyzed for the presence of lipid AGEs, apoprotein AGEs, and oxidative modification (Fig. 5) (Fig.  4) . There also appeared to be a marked increase in the level of lipid AGEs relative to the level of apoprotein-associated AGEs. Linear regression analysis of these data revealed a significant correlation between the level ofAGE modification and LDL oxidation. For the measurement ofAGE apoprotein versus LDL oxidation, this analysis showed a correlation coefficient of r = 0.52 and P < 0.01. For AGE lipid versus LDL oxidation, the corresponding values were r = 0.63 and P < 0.005. Incubation of purified LDL with glucose produces AGE moieties that are attached to both the apoprotein and the lipid components. Under these model in vitro conditions, lipid AGEs form at a faster rate than apoprotein AGEs. LDL that is incubated with glucose also undergoes progressive, oxidative modification concomitantly with advanced glycosylation. Aminoguanidine, an inhibitor of advanced glycosylation, was observed to inhibit both processes: apoprotein and lipid advanced glycosylation and oxidative modification.
Oxidation of the lipid component of LDL has been proposed to play a central role in the pathogenesis of atherosclerosis. Nevertheless, the biochemical processes that initiate lipid oxidation in vivo remain poorly defined. The advanced glycosylation reaction between phospholipid and glucose described in this study provides a facile mechanism to explain the progressive, oxidative modification of lipids in vivo. Evidence in support of this pathway includes the direct relationship between advanced glycosylation and oxidative modification in vitro and the analysis of human LDL specimens, which shows a close association between the levels of lipid AGEs and lipid oxidation products in vivo. There are data to suggest that glucose or Amadori products themselves may enhance free radical formation (34, 35); however, the time course for formation of lipid oxidation products indicates that oxidative modification occurs only after more advanced 'glycosylation reactions have taken place. The precise interaction between AGEs and unsaturated fatty acid residues remains to be elucidated but presumably involves inter-and intramolecular oxidations-reductions and transient free radical formation that occur during advanced glycosylation (13, 14, 36, 37) .
Lipid AGEs were found to be elevated almost 4-fold in diabetic patients, in contrast to apoprotein AGEs, which were elevated 2-fold when diabetic individuals were compared to normal controls. Measurement of lipid-linked AGEs may serve as a convenient, surrogate marker for lipid oxidation and prove useful in assessing the contribution of advanced glycosylation and lipid oxidation to the vascular sequelae of diabetes, chronic renal failure, and normal aging. It is noteworthy that there is close similarity between the spectral properties of lipid AGEs and the age-related pigment lipofuscin (38). The accumulation of lipofuscin and related lipophilic products within neurons, cardiac myocytes, and other long-lived cells may be due in part to the advanced glycosylation reactions between glucose and phospholipids.
In conclusion, amine-containing phospholipids react with glucose to initiate advanced glycosylation reactions, forming lipid-linked AGEs and promoting fatty acid oxidation. This process, termed AGE oxidation, appears to result from the inter-and intramolecular oxidation-reduction reactions that are an inherent feature of advanced glycosylation chemistry. Lipid-advanced glycosylation and oxidation increase during the chronic hyperglycemia of diabetes and support the concept that AGE oxidation plays an important and perhaps primary role in initiating lipid oxidation in vivo.
